FDA Approves Alecensa for ALK-Positive NSCLC
Drug is designed to block the effects of the ALK protein
Herpes Zoster Risk in RA Up With Older Age, Prednisone Dose
HZ risk comparable after initiation of TNFi, non-TNFi, and conventional synthetic DMARDs
Seven Behaviors Suggested to Improve ‘Art of Medicine’
Seven behaviors promote more consistent practice of interpersonal aspects of medicine
Industry-Led Oncology Trials May Inflate Cost-Effectiveness
Breast cancer cost-effectiveness analyses show favorable estimates with industry funding
Toxic Skin Effects Common With EGFR-TKI Use in NSCLC
Afatinib therapy linked to earlier paronychia onset; more dermatological visits for skin toxic effects
SABCS: Tamoxifen, Anastrozole Both Prevent Recurrence in DCIS
However, side effects differ for the two medications
FDA Approves Vistogard to Treat Chemotherapy Overdose
For overdose of the chemo drugs fluorouracil and capecitabine
Nutraceuticals Alone or With Ezetimibe Aid in Dyslipidemia
Improvement in lipid profile for nutraceuticals alone or in combo for statin-intolerant patients
Mindfulness Tx Aids Cancer-Linked Cognitive Impairment
Benefits for breast and colorectal cancer survivors with mindfulness-based stress reduction
Cognitive Therapy, Meds Equally Effective for Major Depression
Researchers find both treatments can benefit patients with major depressive disorder
